Key Events This Week
23 Feb: Technical momentum shifts amid bearish signals
24 Feb: Valuation metrics improve, signalling enhanced price attractiveness
27 Feb: Technical momentum shifts again amid mixed market signals
Week Close: Rs.77.38 (+3.02%) vs Sensex (-0.96%)

Anuh Pharma Ltd is Rated Sell by MarketsMOJO
2026-02-27 10:10:17Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 February 2026, providing investors with the most recent insights into the company’s performance and outlook.
Read full news article
Anuh Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-02-27 08:02:05Anuh Pharma Ltd, a player in the Pharmaceuticals & Biotechnology sector, has experienced a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish trend. Despite a recent day gain of 3.73%, the company’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others remain subdued. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors.
Read full news article
Anuh Pharma Ltd Valuation Shifts Signal Improved Price Attractiveness Amid Mixed Market Returns
2026-02-24 08:02:23Anuh Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven primarily by a decline in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This revaluation comes amid a mixed performance backdrop in the Pharmaceuticals & Biotechnology sector, where peer comparisons and historical benchmarks provide a nuanced perspective on the stock’s price attractiveness and investment potential.
Read full news article
Anuh Pharma Ltd Technical Momentum Shifts Amid Bearish Signals
2026-02-23 08:02:29Anuh Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. Despite some mildly bullish weekly signals, the overall technical landscape suggests caution for investors as the stock navigates downward pressures amid mixed momentum readings.
Read full news article
Anuh Pharma Ltd is Rated Sell by MarketsMOJO
2026-02-16 10:10:24Anuh Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article








